Rigorous study of Xyrem®/sodium oxybate use among patients with obstructive sleep apnea and other conditions of compromised respiratory function is critically needed.
Zvosec
Deborah L
DL
Smith
Stephen W
SW
Mahowald
Mark W
MW
D018592:Cross-Over Studies; D006801:Humans; D006993:Hypnotics and Sedatives / Q000009:adverse effects / Q000627:therapeutic use*; D020181:Sleep Apnea, Obstructive / Q000188:drug therapy*; D012978:Sodium Oxybate / Q000009:adverse effects / Q000627:therapeutic use*
D006993:Hypnotics and Sedatives; D012978:Sodium Oxybate